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The ventral portion of medial prefrontal cortex (vMPFC) is involved
in contextual fear-conditioning expression in rats. In the present
study, we investigated the role of local N-methyl-D-aspartic acid
(NMDA) glutamate receptors and nitric oxide (NO) in vMPFC on the
behavioral (freezing) and cardiovascular (increase of arterial
pressure and heart rate) responses of rats exposed to a context
fear conditioning. The results showed that both freezing and
cardiovascular responses to contextual fear conditioning were
reduced by bilateral administration of NMDA receptor antagonist
LY235959 (4 nmol/200 nL) into the vMPFC before reexposition to
conditioned chamber. Bilateral inhibition of neuronal NO synthase
(nNOS) by local vMPFC administration of the Nv-propyl-L-arginine
(N-propyl, 0.04 nmol/200 nL) or the NO scavenger carboxy-PTIO (1
nmol/200 nL) caused similar results, inhibiting the fear responses.
We also investigated the effects of inhibiting glutamate- and NO-
mediated neurotransmission in the vMPFC at the time of aversive
context exposure on reexposure to the same context. It was
observed that the 1st exposure results in a signiﬁcant attenuation
of the fear responses on reexposure in vehicle-treated animals,
which was not modiﬁed by the drugs. The present results suggest
that a vMPFC NMDA--NO pathway may play an important role on
expression of contextual fear conditioning.
Keywords: cardiovascular system, fear conditioning, freezing,
glutamatergic system, infralimbic cortex, nitric oxide
Introduction
Contextual fear conditioning is evoked by animal reexposure to
an environment (context) that has been previously paired with
an aversive or unpleasant stimulus. This is the case where a rat
is reexposed to the chamber in which it has previously
received electric footshocks (Blanchard RJ and Blanchard
DC 1969; Fanselow 1980; LeDoux et al. 1988; Carrive 2000).
In rats, contextual fear conditioning causes freezing immobility,
and mean arterial pressure (MAP) and heart rate (HR) increases
(Fanselow 1980; LeDoux et al. 1988; Carrive 2002; Resstel,
Joca, Moreira, et al. 2006). Contextual fear conditioning is
associated with a marked increase in neuronal activity in limbic
structures involved with defense reactions, such as the ventral
portion of medial prefrontal cortex (vMPFC) (Beck and Fibiger
1995).
The vMPFC is involved in the behavioral and cardiovascular
responses associated with stress situations (Frysztak and
Neafsey 1991, 1994; Blum et al. 2006; Resstel, Joca, Guimara ˜ es
et al. 2006; Sierra-Mercado et al. 2006; Tavares and Corre ˆ a
2006). We have recently showed that this structure is also
important for the freezing and cardiovascular responses evoked
by contextual fear-conditioning expression (Resstel, Joca,
Guimara ˜ es, et al. 2006). However, which neurotransmitters
are involved in these responses is still unclear.
Both glutamatergic terminals and N-methyl-D-aspartic acid
(NMDA) receptors are present in the vMPFC of rats (Gigg et al.
1994; Nicolle and Baxter 2003). During stress conditions,
glutamate levels are increased in the vMPFC (Moghaddam
1993). Moreover, the glutamatergic stimulation of the vMPFC
was reported to modulate the parasympathetic component of
baroreﬂex (Resstel and Corre ˆ a 2006b), cardiac sympathetic
activity (Resstel and Corre ˆ a 2005), and blood pressure (Resstel
and Corre ˆ a 2006a). These cardiovascular responses were
similar to those observed during defense responses (Nosaka
1996; Resstel, Joca, Guimara ˜ es, et al. 2006; Resstel, Joca,
Moreira, et al. 2006; Tavares and Corre ˆ a 2006). These results
suggest that a glutamate-mediated neurotransmission in the
vMPFC may play a role in fear-conditioning responses.
Glutamate acting on NMDA receptors in the central nervous
system activates the enzyme neuronal nitric oxide synthase
(nNOS), resulting in nitric oxide (NO) formation (Garthwaite
et al. 1988; Garthwaite and Boulton 1995). The cardiovascular
responses evoked by glutamate in the vMPFC depend on NMDA
receptor--NO interaction (Resstel and Corre ˆ a 2006a, 2006b).
Therefore, it is possible that, similar to NMDA receptors, NO is
also involved in fear-conditioning responses regulated by the
vMPFC. To test this hypothesis, we examined the effects of
bilateral injections of the selective NMDA antagonist LY235959,
the selective neuronal NOS inhibitor Nx-propyl-L-arginine (N-
propyl), or the NO scavenger carboxy-PTIO (c-PTIO) injected
into the vMPFC of rats submitted to a contextual fear-
conditioning protocol. The possible involvement of other
subtypes of glutamate ionotropic receptors in this process was
alsoinvestigatedbyinjectingtheselectivenon-NMDAionotropic
glutamate receptor antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-
benzo[f]quinoxaline-2,3-dione (NBQX) into the vMPFC. Finally,
because memory expression depends on the context in which
memoryisretrieved(Spear1973;TulvingandThomson1973)and
reexposure to this context could engage either extinction or
reconsolidation processes (Duvarci and Nader 2004), we also
investigatedtheeffects ofinhibitingglutamate-and NO-mediated
neurotransmission in the vMPFC at the time of aversive context
exposure on reexposure to the same context.
Materials and Methods
Animal Preparation
One hundred and seven male Wistar rats weighing 230--270 g were
used. Animals were kept in the Animal Care Unit of the Department of
Pharmacology, School of Medicine of Ribeira ˜ o Preto, University of Sa ˜ o
Paulo. Rats were housed individually in plastic cages with free access to
food and water and under a 12-h light:dark cycle (lights on at 06:30 h).
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Seven days before the experiment, rats were anesthetized with
tribromoethanol (250 mg/kg ip). After scalp anesthesia with 2%
lidocaine, the skull was surgically exposed, and stainless steel guide
cannulas (26 gauge) were implanted bilaterally in the vMPFC using
a stereotaxic apparatus (Stoelting, IL). Coordinates for cannula implan-
tation (AP = +2.2 mm; L = 2.8 mm from the medial suture, V = –3.3 mm
fromtheskullwithalateralinclinationof23)wereselectedfromtherat
brain atlas of Paxinos and Watson (1997). A control group of animals had
stainless steel guide cannulas implanted bilaterally into surrounding
structures of the vMPFC such as the cingulate cortex area 1 (AP = +1.2
mm;L = 1.5mmfromthemedialsuture,V = –2.3mmfromtheskull),the
corpus callosum (AP = +1.2 mm; L = 2.8 mm from the medial suture,
V = –2.3 mm from the skull), and the tenia tecta (AP = +1.2 mm; L = 3
mm from the medial suture, V = –4.3 mm from the skull).
Cannulas were ﬁxed to the skull with dental cement and 1 metal
screw. One day before experiments, rats were anesthetized with
tribromoethanol and a catheter (a 4-cm PE-10 segment heat bound to
a 13-cm PE-50 segment, Clay-Adams, CA) was inserted into the abdomi-
nal aorta through the femoral artery for blood pressure recording. The
catheter was tunneled under the skin and exteriorized on the animal’s
dorsum.
Drugs
LY235959 (Tocris), NBQX (Tocris), Nx-propyl-L-arginine (Tocris) and
carboxy-PTIO (S)-3-Carboxy-4-hydroxyphenylglicine (c-PTIO, RBI),
tribromoethanol (Aldrich), and urethane (Sigma) were dissolved in
sterile artiﬁcial cerebrospinal ﬂuid (composition: NaCl 100 mM, Na3PO4
2 mM, KCl 2.5 mM, MgCl2 1 mM, NaHCO3 27 mM, CaCl2 2.5 mM;
pH = 7.4).
Fear Conditioning and Testing
Habituation, conditioning, and testing were carried out in 25 3 22 3 22
cm footshock chambers. The chambers had a grid ﬂoor composed of 18
stainless steel rods (2 mm in diameter), spaced 1.5 cm apart and wired
to a shock generator (Automatic Reﬂex Conditioner, model 8572—Ugo
Basile, Comerio, Italy). The chambers were cleaned with 70% ethanol,
before and after use. Preconditioning started 1 week after guide
cannula implantation and consisted of two 10-min-long preexposures
(habituation) to the footshock chamber (1 in the morning and 1 in the
afternoon). In the conditioning shock session, performed 24 h after the
1st habituation session, animals were divided into 2 experimental
groups: nonconditioned and conditioned. The nonconditioned group
was exposed to the footshock chamber for 10 min, but no shock was
delivered. The conditioned group was submitted to a shock session
consisting of 6 electric 2.5 mA/3-s footshocks (Resstel, Joca, Guimara ˜ es,
et al. 2006; Resstel, Joca, Moreira, et al. 2006) delivered at 20-s to 1-min
intervals. After the conditioning session, a catheter was implanted into
the femoral artery for blood pressure and HR recording.
Cardiovascular and behavioral (freezing) responses evoked by
conditioned emotional response to context were evaluated 1 day after
the conditioning. The test session (day 1) consisted of a 10-min-long
reexposure to the footshock chamber without shock delivery. Animals
were transferred from the animal room to the procedure room (a
different room was used for conditioning) in their home box. MAP and
HR were recorded using an HP-7754A ampliﬁer (Hewlett Packard, CA)
connected to a signal acquisition board (Biopac M-100, CA) and
computer processed. Rats were tested 1 at a time. After a few minutes
of baseline recording, injections were performed into the vMPFC. Two
33-gauge needles (Small Parts, Miami Lakes, FL), 1 mm longer than the
guide cannulas, connected to 10-lL syringe (7001KH, Hamilton Co,
NV) through PE-10 tubing, were used. The needles were carefully
inserted into the vMPFC guide cannulas, and the solutions were infused
over a 15-s period in a ﬁnal volume of 200 nL (each side). They
remained in place for an additional 30-s period to prevent reﬂux. Ten
minutes later, animals were replaced in the footshock chamber.
Additional groups of animals were submitted to another 10-min-long
reexposure to context, after 7 days of conditioning. With the exception
of these animals (that were then tested twice in the aversively
conditioned box), all animals were tested only once.
Freezing was evaluated during the test by an experimenter that sat
30 cm away from the footshock chamber and was blind to the
treatment groups. Freezing was deﬁned as the complete absence of
movement while the animal assumed a characteristic tense posture
(Fanselow 1980). We also evaluated animal activity during the test
session by counting the number of crossings and rearings. A crossing
was recorded when the animal crossed with 4 paws the imaginary line
that divide the test chamber into 2 halves.
Experimental Design
Animals were divided into 2 groups: fear-conditioned rats and
nonconditioned rats. Both groups received either 200 nL of vehicle
or the speciﬁc NMDA receptor antagonist LY235959 (4 nmol, Resstel
and Corre ˆ a 2006a, 2006b), the speciﬁc non-NMDA receptor antagonist
NBQX (4 nmol, equimolar dose to that of LY235959), the nNOS
inhibitor N-propyl (0.04 nmol, Zhang et al. 1997; Resstel and Corre ˆ a
2006a, 2006b), or the NO scavenger c-PTIO (1 nmol, Aguiar et al. 2006;
Tavares et al. 2007) bilaterally injected into the vMPFC 10 min prior the
test session. All doses were based on previous studies.
On day 7 (reexposition test), only fear-conditioned rats which had
received drug administration (LY235959 and N-propyl) or vehicle prior
the test (day 1) were reexposed to context. A nonexposed, control
animal group, that also received LY235959, N-propyl, or vehicle
injections on day 1, was exposed to the aversively conditioned context
on day 7.
Histological Procedure
At the end of the experiments, the rats were anesthetized with
urethane (1.25 g/kg, ip), and 200 nL of 1% Evan’s blue dye was
bilaterally injected into the vMPFC to mark the injection site. The chest
was surgically opened; the descending aorta occluded; the right atrium
severed; and the brain perfused with 10% formalin through the left
ventricle. Brains were postﬁxed for 24 h at 4 C, and 40-lm sections
were cut using a cryostat (CM-1900, Leica, Wetzlar, Germany). Serial
brain sections were stained with 1% neutral red and injection sites
determined using the rat brain atlas of Paxinos and Watson (1997) as
reference.
Data Analysis
MAP and HR values were continuously recorded during the 5-min
period before and the 10-min period after exposure to the footshock
chamber. Data were expressed as means ± standard error of the mean
of MAP or HR changes (respectively DMAP and DHR) sampled at 60-s
intervals. Points sampled during the 300 s before exposure were used
as control baseline value. MAP and HR changes were analyzed using 3-
way analysis of variance (ANOVA) with group (conditioned or
nonconditioned) and treatment (drug or vehicle) as main independent
factors and time as repeated measurement. When interaction between
the factors was observed, groups were compared at speciﬁc times using
the Bonferroni’s post hoc test.
Freezing was expressed as percentage of the whole test period
(600 s). Freezing, crossings, and rearings were analyzed using 2-way
ANOVA with condition (conditioned or nonconditioned) and treat-
ment (drug or vehicle) as the 2 factors. When interaction between the
factors was observed, speciﬁc 1-way ANOVA followed by the
Bonferroni post hoc test was performed.
The cardiovascular and behavior responses observed at reexposition
test (day 7) were analyzed as described above, with day of exposition
(day 1 or day 7) and treatment (drug or vehicle) as main independent
factors. P < 0.05 was assumed as statistically signiﬁcant.
Results
Diagrammatic representation indicating the injection sites of
vehicle and all drugs and a photomicrograph showing
a representative bilateral injection site in the vMPFC are
presented in Figure 1.
Comparedwiththegroup(n = 5),whichreceivedvehicleinto
the vMPFC, no changes were observed in behavior (F3,19 = 0.1,
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0.05andHR:F3,285 = 0.62,P > 0.05)whenLY,N-propyl,orc-PTIO
were microinjected into structures vMPFC surrounding such as
the cingulate cortex area 1 (n = 6), the corpus callosum (n = 6),
or the tenia tecta (n = 6) during the chamber reexposition test.
Behavioral Responses to Contextual Fear Conditioning
There were signiﬁcant effects of condition (F4,40 = 29.3, P <
0.001), treatment (F1,40 = 34.2, P < 0.001), and interaction
between the 2 factors (F4,40 = 25.1, P < 0.001) on time spent
in freezing behavior. Vehicle-treated rats pre-exposed to
shocks (conditioned group) spent more time in freezing than
non--pre-exposed controls (nonconditioned group) during the
reexposure to context (Fig. 2). One-way ANOVA indicated
a signiﬁcant effect for treatment on conditioned animals
(F4,20 = 16, P < 0.001). The bilateral injection into the vMPFC
of LY (n = 5), N-propyl (n = 5), or c-PTIO (n = 5) reduced the
time spent in freezing on conditioned animals when compared
with respective vehicle-treated group (n = 5, Fig. 2). NBQX (n =
5) did not change time spent in freezing of conditioned animals
(P > 0.05, Fig. 2). In nonconditioned animals, no signiﬁcant
treatment effect was found (F4,20 = 0.3, P > 0.05, Fig. 2).
Two-way ANOVA indicated signiﬁcant effects of condition-
ing (F1,40 = 14.3, P < 0.01), treatment (F4,40 = 35.4, P < 0.001),
and interaction (F4,40 = 19.2, P < 0.001) on the number of
crossings. Further analysis showed that vehicle-treated rats pre-
exposed to shocks (n = 5) present a small number of crossings
compared with non--pre-exposed controls (n = 5, t = 6.5, df = 8,
P < 0.01, Fig. 3).
Similar effects of conditioning (F1,40 = 22.3, P < 0.001),
treatment (F4,40 = 18.5, P < 0.001), and interaction (F4,40 = 22.4,
P < 0.001) were observed on the number of rearings. Vehicle-
treated rats pre-exposed to shocks (n = 5) showed a smaller
number of rearings than non--pre-exposed controls (n = 5, t =
5.3, P < 0.001, df = 8, Fig. 3).
Bilateral injection of LY, N-propyl, and c-PTIO into the vMPFC
signiﬁcantly increased the number of crossings (F4,20 = 25.4, P <
0.001) and rearings (F4,20 = 13.4, P < 0.001) of conditioned
animals when compared with vehicle-treated animals (Fig. 4).
No drug effect was found in nonconditioned animals (crossings,
F4,20 = 1.3; rearings, F4,20 = 0.8, P > 0.05, ig. 3).
Cardiovascular Responses to Contextual Fear
Conditioning
In both group, bilateral injection of LY, N-propyl, NBQX, and
c-PTIO into the vMPFC had no effect on basal levels of MAP
and HR.
There were signiﬁcant effects of condition, treatment, and
condition versus time interaction on both HR (condition:
F1,39 = 28.4, P < 0.01; condition vs. time: F14,546 = 9.8) and MAP
(condition: F1,39 = 4.5, P < 0.05; condition vs. time: F14,546 =
13.7, P < 0.01). For these variables, there were also signiﬁcant
effects of treatment (HR: F4,39 = 16.1, P < 0.01; MAP: F4,39 = 15.6,
P < 0.01), condition versus treatment (HR: F4,39 = 2.4, P > 0.05;
MAP: F4,39 = 2.1, P > 0.05), and condition versus treatment
versus time interactions on HR (F56,546 = 1.5, P < 0.05) but not
in MAP (F56,546 = 1.2, P > 0.05).
In the nonconditioned group, reexposure to the context
induced an increase in HR and MAP, although smaller than that
observed in the conditioned group (MAP: F1,120 = 64.3, P < 0.01
and HR: F1,120 = 104.8, P < 0.01) (Fig. 4). Treatment effects
were signiﬁcant on both conditioned (MAP: F1,136 = 159.5, P <
0.001 and HR: F1,136 = 164.7, P < 0.001) and nonconditioned
(MAP: F1,136 = 34.7, P < 0.001 and HR: F1,136 = 104.8, P < 0.001)
groups. In these groups, bilateral injection of LY, N-propyl, and
c-PTIO into the vMPFC signiﬁcantly reduced the increase in
MAP and HR. NBQX did not signiﬁcantly affect HR and MAP in
any experimental group (Fig. 4).
Behavioral and Cardiovascular Responses to Contextual
Fear Conditioning During a Second Reexposure to the
Aversive Context
Seven days after the conditioning session, conditioned animals
that received vehicle, LY, or N-propyl on day 1 (test) were
Figure 1. (A) Photomicrograph of a coronal brain section showing bilateral microinjections sites in the vMPFC. (B) Diagrammatic representation based on the rat brain atlas of
Paxinos and Watson (1997) indicating the drugs sites into the vMPFC (closed circles). Animals with drug injection sites outside the vMPFC were represented by opened circles.
Cg1, cingulate cortex area 1; PL, prelimbic cortex; IL, infralimbic cortex; DP, dorsal peduncular cortex; cc, corpus callosum; and TT, tenia tecta. IA, interaural.
Figure 2. Effects of bilateral microinjection of 200 nL of vehicle, 4 nmol of LY235959
(LY),4nmolofNBQX,0.04nmolofN-propyl,or1nmolofc-PTIOinthepercentageoftime
spent in freezing behavior of nonconditioned and fear-conditioned rats (n 5 5/group).
Columns represent the mean and bars the SEM, *P \ 0.05 (compared with vehicle
nonconditioned group) and #P\0.05 (compared with vehicle-conditioned group).
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of treatment (F2,24 = 11.4, P < 0.01), day of exposition (F1,24 =
21.9, P < 0.01), and interaction between the 2 factors (F2,24 =
9.8, P < 0.01) on time spent in freezing behavior. Vehicle-
treated rats showed a signiﬁcant decrease in freezing on day 7
compared with day 1 (n = 5, P < 0.01, Fig. 5). Bilateral injection
into the vMPFC of LY (n = 5) and N-propyl (n = 5) reduced the
time spent in freezing when compared with respective vehicle-
treated group on day 1 (F2,12 = 21.4, P < 0.001). This reduction
was maintained when the same animals were tested on day 7
(F2,12 = 0.7, P > 0.05, Fig. 5). The autonomic responses of these
animals were shown in Figure 6. There were signiﬁcant effects
of treatment, day of exposition, and interaction between the 2
factors on both HR (treatment: F2,120 = 131.3, P < 0.01; day of
exposition: F1,120 = 10.36, P < 0.01; interaction: F14,120 = 4.9, P <
0.01) and MAP (treatment: F2,120 = 123.4, P < 0.01; day of
exposition: F1,120 = 9.3, P < 0.01; interaction: F14,120 = 3.4, P <
0.01). Similar to the behavioral responses, control animals
showed decreased cardiovascular responses on day 7 (MAP:
F1,120 = 119.3, P < 0.01 and HR: F1,120 = 243.2, P < 0.001)
Figure 3. Effects of bilateral microinjection of 200 nL of vehicle, 4 nmol of LY235959 (LY), 4 nmol of NBQX, 0.04 nmol of N-propyl, or 1 nmol of c-PTIO in the number of crossings
and rearings of nonconditioned or fear-conditioned rats (n 5 5/group). *P \ 0.05 (compared with vehicle nonconditioned group) and #P \ 0.05 (compared with vehicle-
conditioned group). Further speciﬁcations as in ﬁgure 2.
Figure 4. Time course of the effects of bilateral microinjection of 200 nL of vehicle, 4 nmol of LY235959 (LY), 4 nmol of NBQX, 0.04 nmol of N-propyl, or 1 nmol of c-PTIO
in the mean arterial pressure (DMAP) and heart rate (DHR) recorded in nonconditioned and fear-conditioned rats (n 5 5/group). Asterisk indicates signiﬁcant treatment effect
(P \ 0.05) compared with vehicle- and NBQX-treated animals. Further speciﬁcations as in ﬁgure 2.
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propyl (n = 5) reduced the cardiovascular responses when
compared with control group on day 1 (MAP: F2,180 = 87.1, P <
0.001 and HR: F2,180 = 112.7, P < 0.001). This reduction was also
maintained when the same animals were tested on day 7 (MAP:
F2,180 = 1.3, P > 0.05 and HR: F1,180 = 1.8, P > 0.05, Fig. 6).
There were no differences among animals that received
vehicle, LY or N-Propyl (n=8, each group) on day 1 and were
exposed to the context on day 7. However, they all showed
freezing (table 1) and cardiovascular responses (data not shown)
similar to vehicle-treated animals tested 24 h after conditioning
(P > 0.05).
Discussion
The present results showed that reexposure 1 or 7 days to
a context previously paired with aversive (footshock) stimulus
induces an almost immediate increase in MAP and HR. These
effects were associated with signiﬁcant behavioral changes,
with the conditioned animals spending almost 80% of the time
in freezing behavior. Therefore, the present study was able to
reproduce the behavioral and autonomic responses typically
observed in studies employing contextual fear-conditioning
paradigms (Carrive 2000; Zhang et al. 2004, Resstel, Joca,
Guimara ˜ es, et al. 2006; Resstel, Joca, Moreira, et al. 2006).
The MPFC is anatomically deﬁned as the cortical area
receiving afferent projections from the medial dorsal thalamic
nucleus. Iontophoretic studies identiﬁed L-glutamine as the
neurotransmitter in the MPFC projection from the medial
dorsal thalamic nucleus (Gigg et al. 1992). In addition, binding
experiments showed that ionotropic glutamate receptors are
Figure 5. Effects of bilateral microinjection of 200 nL of vehicle, 4 nmol of LY235959
(LY), or 0.04 nmol of N-propyl in the percentage of time spent in freezing behavior
of fear-conditioned rats (n 5 5/group) 10 min before the 1st reexposition of context
(day 1) and 6 days before the 2nd reexposition to context (day 7). Columns represent
the mean and bars the SEM, *P \ 0.05, compared with vehicle-conditioned group
in day 1.
Figure 6. Time course of the effects of bilateral microinjection of 200 nL of vehicle, 4 nmol of LY235959 (LY), or N-propyl in the mean arterial pressure (DMAP) and heart rate
(DHR) recorded in fear-conditioned rats (n 5 5/group) 10 min before the 1st reexposition of context (day 1) and 6 days before the 2nd reexposition to context (day 7). Asterisk
indicates signiﬁcant treatment effect (P \ 0.05) compared with vehicle-treated animals.
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showed that intra-vMPFC administration of LY235959, a selec-
tive NMDA receptor antagonist, blocked the cardiovascular and
freezing responses of conditioned rats exposed to the aversive
context, corroborating previous observations (Benveniste and
Mayer 1991; Dhruva et al. 1998). To exclude a possible
interference of LY235959 on non-NMDA glutamate receptors,
we pretreated rats with the selective non-NMDA antagonist
NBQX (Ohmori et al. 1996). NBQX is more potent than 6-
cyano-7-nitroquinoxaline-2,3-dione (CNQX) to block alpha-
amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)
receptor--mediated effects (Yu and Miller 1995). It was
previously reported by Dhruva et al. (1998) that AMPA
receptors were blocked by a 5-fold lower dose of NBQX than
that of AP-7 (a selective NMDA receptors antagonist less potent
than LY235959) necessary to block NMDA receptors. The
pretreatment with NBQX in dose equimolar to that used of
LY235959 failed to affect the fear-conditioning responses,
suggesting that the effects of LY235959 on fear-conditioning
expression do not involve activation of non-NMDA receptors.
This observation further reinforces the idea of a major
involvement of NMDA receptors in the expression of fear-
conditioning responses. However, considering that only a single
dose of NBQX was used, it is not possible to rule out the
involvement of non-NMDA receptors in these responses.
Because a previous study has shown that administration of a
NMDA receptor antagonist into the vMPFC before the
conditioning test has no effect on freezing induced by a tone
Conditioned Stimulus presentation (Burgos-Robles et al. 2007),
NMDA receptors located in the vMPFC seems to be preferen-
tially associated with emotional responses evoked by fear
conditioning to context rather than speciﬁc cues. Anyway, at
least for contextual fear conditioning, our results argue the
current view that NMDA receptors of the vMPFC are only
involved in the extinction of fear responses.
PreviousstudiesusingFos-likeimunoreactivityshowedthatthe
vMPFC is strongly activated by contextual fear (Beck and Fibiger
1995). Moreover, vMPFC excitotoxic lesions or chemical in-
hibition(FrysztakandNeafsey1991,1994;Blumetal.2006;Sierra-
Mercado et al. 2006) or neurotransmission inhibition (Resstel,
Joca, Guimara ˜ es, et al. 2006) attenuate fear-related responses
in aversive conditioning, elevated-plus maze, and burying tests
(Shah and Treit 2003), suggesting that this cortical region has
a signiﬁcant role in wide varieties of fear and anxiety responses.
Probably reﬂecting the stress induced by our experimental
conditions, nonconditioned rats also presented a signiﬁcant,
although smaller, increase in MAP and HR. However, practically
no freezing response was observed in these animals. Reinforc-
ing the possible involvement of NMDA receptors and NO
synthesis in the vMPFC with cardiovascular responses to stress
(Tavares and Corre ˆ a 2006), NMDA receptor antagonist or drugs
that interfere with NO-mediated neurotransmission attenuated
these changes in MAP and HR.
The involvement of NMDA receptors in the vMPFC with
cardiovascular responses has been investigated by several
studies. L-glutamate administration into the vMPFC evoked
MAP, HR, and sympathetic activity increases (Verberne 1996;
Resstel and Corre ˆ a 2005) through NMDA receptors (Resstel
and Corre ˆ a 2006b). Tachycardia, MAP and sympathetic tonus
increases are associated with emotional arousal and stress
responses (Berntson et al. 1998; Cacioppo et al. 1998; Carrive
2000). Also, the parasympathetic component of the baroreﬂex
is inhibited during stress situations (Nosaka and Murata 1989;
Neafsey 1990; Nosaka 1996), an effect that involves the vMPFC
(Resstel et al. 2004, 2005). This effect is also mediated by local
NMDA receptors (Resstel and Corre ˆ a 2006a) and is character-
ized by a reduction of the parasympathetic activity (Resstel and
Corre ˆ a 2005). Thus, during defensive reactions, activation of
vMPFC NMDA receptors could be modulating the bradycardic
reﬂex and facilitating tachycardic responses.
Garthwaite et al. (1988) 1st reported that L-glutamate, acting
on NMDA receptors in cerebellar cells, releases NO. In recent
years, many electrophysiological and biochemical ﬁndings have
suggested that NO modulates neuronal synaptic function in the
central nervous system (Prast and Philippu 2001). NO pro-
duction by nNOS correlates with activation of NMDA, but not
of other, receptors (Garthwaite and Boulton 1995). This
puzzling correlation was clariﬁed when Brenman and Bredt
(1997) reported that nNOS is connected to NMDA receptors
via a postsynaptic density protein named PSD-95, being directly
exposed to the inﬂux of Ca
2+ caused by activation of NMDA
receptors. The Ca
2+ transients that arise from activation of
other receptors are presumable too diluted when they reach
the vicinity of the enzyme nNOS.
To investigate a possible involvement of NO formation in
contextual fear-conditioning responses, we microinjected the
selective nNOS inhibitor N-propyl into the vMPFC. The drug
abolished the behavior and cardiovascular responses evoked by
aversive chamber reexposure. N-propyl was reported to be
3000 and 150 fold more potent to inhibit nNOS than inducible
or endothelial NOS, respectively (Hevel et al. 1991; Martasek
et al. 1996; Zhang et al. 1997). Conﬁrming the involvement of
NO in vMPFC effects, the contextual fear-conditioning res-
ponses were also blocked by c-PTIO, a NO scavenger, at a dose
that was able to produce anxiolytic-like effects after injection
into the dorsolateral periaqueductal gray (Aguiar et al. 2006).
NO acts primarily as an intercellular messenger (Guix et al.
2005). It diffuses rapidly and inﬂuences target cells within
a spatial sphere of approximately 0.3--0.4 mm of diameter
(Wood and Garthwaite 1994; Lancaster 1997). Thus, NO can
inﬂuence neuronal or glial cells far away from its neuron source
(Wood and Garthwaite 1994; Lancaster 1997). Because c-PTIO
is a cell membrane--impermeable compound (Ko and Kelly
1999), the present ﬁndings indicate that both NOS activation
and extracellular release of NO in the vMPFC are involved in
conditioned emotional responses.
The vMPFC is implicated in both learning and memory
processes (Kesner et al. 1996; Ragozzino et al. 1998) and in the
regulation of emotional behaviors (Morgan et al. 1993; Jinks
and McGregor 1997; Quirk et al. 2000). It plays a crucial role in
Table 1
Effects of bilateral microinjection of 200 nL of vehicle (tested at day 1 and day 7 or only in day 7),
4 nmol of LY235959 (LY), or 0.04 nmol of N-propyl in the percentage of time spent in freezing
behavior of fear-conditioned rats 10 min before the 1st reexposition of context (day 1) and 6
days before the 2nd reexposition to context (day 7)
Group Freezing (%)
Day 1 Day 7
Vehicle (n 5 5) 74 ± 5 13 ± 4*
Vehicle (n 5 8) Not exposed 80 ± 3
LY (n 5 8) Not exposed 74 ± 5
N-propyl (n 5 8) Not exposed 82 ± 4
Data represent the mean ± standard error of the mean.
*P \ 0.05 compared with vehicle in day 1.
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responses (Sesack et al. 1989; Takagishi and Chiba 1991; Conde
et al. 1995). Efferent projections connect the vMPFC to
structures involved in fear-conditioning expression such as
the periaqueductal gray matter, amygdala, hippocampus, and
hypothalamus (Sesack et al. 1989; Fendt and Fanselow 1999;
LeDoux 2000; Murphy et al. 2000). The vMPFC receives
information about context and electrical shock associations
through afferents from the amygdala and the hippocampus
(Jay and Witter 1991). Both the hippocampus and the amygdala
have been implicated in the associative processes underlying
formation of conditioned fear (Fanselow and LeDoux 1999;
LeDoux 2000; Bast et al. 2003). Moreover, lesions of the
hippocampus or amygdala decreased conditioned fear cardio-
vascular responses (Galeno et al. 1984; Gentile et al. 1986;
Iwata et al. 1986; LeDoux et al. 1988; Kim and Fanselow 1992;
Maren and Fanselow 1997; Maren et al. 1997; Anagnostaras et al.
1999).
The basolateral amygdala sends glutamatergic projections to
the central amygdala (Pitkanen et al. 1997). This nucleus is the
main source of amygdala outputs to the brain stem and
hypothalamic sites (Holstege et al. 1996) that mediate the
behavioral and autonomic responses associated with fear
(LeDoux et al. 1988; De Oca et al. 1998). Projections from
the central amygdala are thought to mediate behavioral
components of conditioned fear reactions (LeDoux et al.
1988; Helmstetter 1992). It has been proposed that vMPFC
modulates conditioned fear responses via its projections to the
amygdala (al Maskati and Zbrozyna 1989; Morgan et al. 1993;
Rosenkranz and Grace 2001; Royer and Pare ´ 2002). In addition,
Quirk et al. (2003) observed that stimulation of the vMPFC
alters the central amygdala neurons activity to basolateral
amygdala inputs provide direct physiological support for the
hypothesis that the vMPFC modulates fear responses by
amygdala output (Garcia et al. 1999; LeDoux 2000).
Memory expression depends on the context in which
memory is retrieved (Spear 1973; Tulving and Thomson
1973). In addition, reexposure to this context could engage
either extinction or reconsolidation processes, with the latter
initiating a 2nd time-dependent memory formation process
(Duvarci and Nader 2004). To investigate a possible role of
NMDA/NO-mediated neurotransmission in the vMPFC in these
processes, we reexposed rats that had received LY235959 or
N-propyl prior the test (day 1) to the aversive context 6 days
later. The results showed that the 1st exposure causes
a signiﬁcant attenuation of the freezing and cardiovascular
responses on reexposure, which was not modiﬁed by the
drugs. However, if the animals have just received the drug
treatments on day 1 and exposed to the aversive context on
day 7, they will show similar freezing and cardiovascular
responses to vehicle-treated animals exposed on day 1 after
conditioning. This shows that the conditioning effects last for
at least 1 week and are not modiﬁed by blocking of NMDA- or
NO-mediated neurotransmission in vMPFC 1 day after condi-
tioning. They also suggest that under our experimental
conditions the 1st reexposure to the aversively conditioned
context engages extinction processes that does not depend on
NMDA/NO neurotransmission in the vMPFC at the time of
reexposure. Corroborating these results, studies employing
reversible blockade (Sierra-Mercado et al. 2006), NMDA
receptor antagonism (Burgos-Robles et al. 2007), or protein
synthesis inhibition (Santini et al. 2004) of vMPFC at the time of
reexposure of the conditioned stimulus, failed to show any
impairment in fear extinction.
In conclusion, the present results suggest that NMDA
glutamate receptors and NO formation in the vMPFC play an
important role on the expression of the behavioral and
cardiovascular responses observed during fear evoked by
contextual conditioning.
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